Voorbeelden van het gebruik van New active substance in het Engels en hun vertalingen in het Nederlands
{-}
-
Official
-
Medicine
-
Colloquial
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
the internal market works, deserves to be extended to all medicinal products using a new active substance.
This includes advice on whether an active substance of a medicinal product can be identified as a new active substance(NAS status),
like the majority established in the specialised parliamentary committee, am in favour of medicinal products for human use containing a new active substance being able to receive authorisation from the national agencies.
the evaluating competent authority has submitted a recommendation for inclusion of the new active substance in Annex I and the competent authority which received the application for the provisional authorisation
The development of new active substances is time consuming because of the requisite approval procedures.
Evaluation of new active substances: 5/year.
Assessment of new active substances in view of their approval.
Approval of new active substances.
Authorisations of products containing new active substances.
Your argument in favour of the decentralised procedure in the area of new active substances is therefore unfounded,
We do not support the Commission's view that all new active substances for veterinary medicinal products should be authorised under the centralised procedure.
Assessment of new active substances in view of their inclusion in Annex I of the Regulation.
Allowing Member States to extend provisional authorisations granted for the new active substances benzoic acid,
It is now possible to introduce more precision with regard to the data requirements as experience was gained during the evaluation of several new active substances consisting of micro-organisms.
Fees for product authorisation amount to EUR 100,000 for products containing new active substances, to EUR 80,000 for low-risk products.
The centralised procedure usually deals with highly innovative medicinal products, either biotechnological compounds or new active substances.
of application of the directive and the Council's refusal to make the centralised procedure obligatory immediately for all new active substances.
The Council has reduced the period during which all medicinal products containing new active substances must be available only on prescription from seven to five years Article 67, third paragraph.
New active substances should be reviewed before biocidal products containing them could be placed on the market
The new active substances imazamox, oxasulfuron,